Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_assertion description "[We found that YM155 induced apoptosis by broad-spectrum inhibition of IAP family member proteins (e.g., CIAP1/2 and FLIP) and induced proapoptotic Bak protein upregulation and activation; the antitumor effect of YM155 treatment with either the DR5 agonist lexatumumab or gemcitabine on pancreatic cancer cells was synergistic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_assertion evidence source_evidence_literature NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_assertion SIO_000772 25344582 NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_assertion wasDerivedFrom befree-2016 NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_assertion wasGeneratedBy ECO_0000203 NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.
- befree-2016 importedOn "2016-02-19" NP1232490.RACBrZ5eto_NHRu7kLOy3G2tJpXQxoqvxlOYRl8_sNRks130_provenance.